Yuki Hashimoto

1.8k total citations
73 papers, 1.4k citations indexed

About

Yuki Hashimoto is a scholar working on Dermatology, Rheumatology and Immunology. According to data from OpenAlex, Yuki Hashimoto has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Dermatology, 16 papers in Rheumatology and 12 papers in Immunology. Recurrent topics in Yuki Hashimoto's work include Dermatology and Skin Diseases (23 papers), Urticaria and Related Conditions (14 papers) and Contact Dermatitis and Allergies (10 papers). Yuki Hashimoto is often cited by papers focused on Dermatology and Skin Diseases (23 papers), Urticaria and Related Conditions (14 papers) and Contact Dermatitis and Allergies (10 papers). Yuki Hashimoto collaborates with scholars based in Japan, United States and Australia. Yuki Hashimoto's co-authors include Iwao Arai, Shiro Nakaike, Nobuko Futaki, Yusuke Honma, Masanori Sugimoto, Takanobu Sakurai, Tomoko Watanabe, Kiyoshi Kurokawa, Teruhiko Matsushima and T Teramoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and FEBS Letters.

In The Last Decade

Yuki Hashimoto

64 papers receiving 1.3k citations

Peers

Yuki Hashimoto
Jean Kim United States
David S. Hill United Kingdom
Michael P. O’Connor United States
Mary Ellen Dahlgren United States
David Goldstein United States
Ilse M. Beck Belgium
Roland Lang Austria
Yuki Hashimoto
Citations per year, relative to Yuki Hashimoto Yuki Hashimoto (= 1×) peers Hiroko Saito

Countries citing papers authored by Yuki Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Yuki Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Hashimoto more than expected).

Fields of papers citing papers by Yuki Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Hashimoto. The network helps show where Yuki Hashimoto may publish in the future.

Co-authorship network of co-authors of Yuki Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Hashimoto. A scholar is included among the top collaborators of Yuki Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Hashimoto. Yuki Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakatake, Richi, Tetsuya Okuyama, Yuki Hashimoto, et al.. (2024). Sulforaphane Is Protective against Warm Ischemia/Reperfusion Injury and Partial Hepatectomy in Rats. International Journal of Molecular Sciences. 25(1). 579–579. 2 indexed citations
2.
Okuyama, Tetsuya, Yuki Hashimoto, Hiroaki Kitade, et al.. (2024). Olprinone, a Selective Phosphodiesterase III Inhibitor, Has Protective Effects in a Septic Rat Model after Partial Hepatectomy and Primary Rat Hepatocyte. International Journal of Molecular Sciences. 25(13). 7189–7189.
3.
Koizumi, M., et al.. (2023). Comparing leak pressure of LMA® ProSeal™ versus i-gel® at head rotation: a randomized controlled trial. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 71(1). 66–76.
4.
Saeki, Hidehisa, Yasumasa Kanai, Kenta Murotani, et al.. (2022). Work productivity in real‐life employed patients with plaque psoriasis: Results from the ProLOGUE study. The Journal of Dermatology. 49(10). 970–978. 8 indexed citations
5.
Koikov, L. N., Renny J. Starner, Viki B. Swope, et al.. (2021). Development of hMC1R Selective Small Agonists for Sunless Tanning and Prevention of Genotoxicity of UV in Melanocytes. Journal of Investigative Dermatology. 141(7). 1819–1829. 17 indexed citations
7.
Hashimoto, Yuki, Mitsuaki Ishida, Hironori Ryota, et al.. (2019). Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis. Pancreatology. 19(3). 443–448. 21 indexed citations
8.
Wada, Shun‐ichi, et al.. (2013). Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells. Bioorganic & Medicinal Chemistry. 21(24). 7669–7673. 24 indexed citations
9.
Ohashi, Norio, et al.. (2009). Two Cases of Cheilitis Granulomatosa. The Nishinihon Journal of Dermatology. 71(2). 137–140.
10.
Hashimoto, Yuki. (2008). Alteration of Concanavalin A Binding Glycoproteins in Cerebrospinal Fluid and Serum of Alzheimer's Disease Patients. Yonago acta medica. 51(1). 1–9. 1 indexed citations
11.
Taniguchi, Miyako, Yuki Hashimoto, Daiki Jimbo, et al.. (2008). Sugar Chains of Cerebrospinal Fluid Transferrin as a New Biological Marker of Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 26(2). 117–122. 33 indexed citations
12.
Hashimoto, Yuki, Hiromi Kanto, & Masatoshi Itoh. (2007). Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. The Journal of Dermatology. 34(8). 577–582. 25 indexed citations
13.
Sugimoto, Masanori, Iwao Arai, Nobuko Futaki, et al.. (2007). The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice. European Journal of Pharmacology. 564(1-3). 196–203. 8 indexed citations
14.
Arai, Iwao, et al.. (2006). Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice. Prostaglandins Leukotrienes and Essential Fatty Acids. 75(1). 1–8. 19 indexed citations
15.
Hashimoto, Yuki, Iwao Arai, Makoto Tanaka, & Shiro Nakaike. (2005). Prostaglandin D2 Inhibits IgE-Mediated Scratching by Suppressing Histamine Release From Mast Cells. Journal of Pharmacological Sciences. 98(1). 90–93. 17 indexed citations
16.
Hashimoto, Yuki, Iwao Arai, Norikazu Takano, Makoto Tanaka, & Shiro Nakaike. (2005). Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis. British Journal of Dermatology. 154(1). 28–33. 25 indexed citations
17.
Takahashi, Nobutaka, Iwao Arai, Yusuke Honma, et al.. (2005). Scratching behavior in spontaneous‐ or allergic contact‐induced dermatitis in NC/Nga mice. Experimental Dermatology. 14(11). 830–837. 29 indexed citations
18.
Arai, Iwao, Norikazu Takano, Yuki Hashimoto, et al.. (2004). Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. European Journal of Pharmacology. 505(1-3). 229–235. 47 indexed citations
19.
Hashimoto, Yuki, et al.. (2003). Menstrual cycles and attitudes were affected by the athletic training of female handball players. 8(2). 161–168. 1 indexed citations
20.
Hashimoto, Yuki, et al.. (2003). Clarithromycin Inhibits the Development of Dermatitis in NC/Nga Mice. Chemotherapy. 49(5). 222–228. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026